Transcriptional networks in epithelial-mesenchymal transition

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Venkov, Christo ^a   Plieth, David ^a   Ni, Terri ^a   Karmaker, Amitava ^b   Bian, Aihua ^a   George Jr , Alfred L ^a   Neilson, Eric G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN STOUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR KLF10; TRANSCRIPTION FACTOR SOX11; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EVI 1 GENE; FIBROBLAST; FTS 1 GENE; GC BOX GENE; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; SRY GENE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CYTOLOGY; DNA RESPONSIVE ELEMENT; DRUG EFFECT; FIBROSIS; GENE REGULATORY NETWORK; GENE SILENCING; GENETICS; KIDNEY PROXIMAL TUBULE; MALE; METABOLISM; PATHOLOGY; REPRODUCIBILITY;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL LINE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GENE KNOCKDOWN TECHNIQUES; GENE REGULATORY NETWORKS; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 80053610850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025354     Document Type: Article

References (71)

1. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
2. Neilson EG, (2006) Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Rev Nephrol 2: 101-108.
3. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
4. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA, (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449.
5. Kalluri R, Neilson EG, (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784.
6. Liu Y, (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-222.
7. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R, (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology: JASN 19: 2282-2287.
8. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, et al. (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961.
9. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
10. Xue C, Plieth D, Venkov C, Xu C, Neilson EG, (2003) The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63: 3386-3394.
11. Zeisberg M, Neilson EG, (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834.
12. Quaggin SE, Kapus A, (2011) Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney international 80: 41-50.
13. Iwano M, (2010) EMT and TGF-beta in renal fibrosis. Frontiers in bioscience 2: 229-238.
14. Okada H, Danoff TM, Kalluri R, Neilson EG, (1997) Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273: F563-574.
15. Venkov CD, Link AJ, Jennings JL, Plieth D, Inoue T, et al. (2007) A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest 117: 482-491.
16. Nieto MA, (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166.
17. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
18. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, et al. (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174: 175-183.
19. Heuberger J, Birchmeier W, (2010) Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harbor perspectives in biology 2: a002915.
20. Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, et al. (2008) A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 22: 756-769.
21. Nawshad A, Medici D, Liu CC, Hay ED, (2007) TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 120: 1646-1653.
22. Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, et al. (2006) Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25: 5603-5613.
23. Pozharskaya V, Torres-Gonzalez E, Rojas M, Gal A, Amin M, et al. (2009) Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis. PLoS One 4: e7559.
24. Levine M, Davidson EH, (2005) Gene regulatory networks for development. Proc Natl Acad Sci U S A 102: 4936-4942.
25. Davidson EH, Levine MS, (2008) Properties of developmental gene regulatory networks. Proc Natl Acad Sci U S A 105: 20063-20066.
26. Blais A, Dynlacht BD, (2005) Constructing transcriptional regulatory networks. Genes Dev 19: 1499-1511.
27. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325.
28. Shoval O, Alon U, (2010) SnapShot: network motifs. Cell 143: 326-e321.
29. Gotea V, Visel A, Westlund JM, Nobrega MA, Pennacchio LA, et al. (2010) Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res 20: 565-577.
30. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, et al. (2010) An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140: 744-752.
31. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe M, et al. (1988) Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107: 1359-1368.
32. Ni TT, Lemon WJ, Shyr Y, Zhong TP, (2008) Use of normalization methods for analysis of microarrays containing a high degree of gene effects. BMC Bioinformatics 9: 505.
33. Dittmer A, Dittmer J, (2006) Beta-actin is not a reliable loading control in Western blot analysis. Electrophoresis 27: 2844-2845.
34. Welinder C, Ekblad L, (2011) Coomassie staining as loading control in Western blot analysis. Journal of proteome research 10: 1416-1419.
35. Pryor JL, Xu W, Hamilton DW, (1992) Immunodetection after complete destaining of coomassie blue-stained proteins on immobilon-PVDF. Analytical biochemistry 202: 100-104.
36. Stahlberg A, Hakansson J, Xian X, Semb H, Kubista M, (2004) Properties of the reverse transcription reaction in mRNA quantification. Clinical chemistry 50: 509-515.
37. Bustin SA, (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of molecular endocrinology 25: 169-193.
38. Bustin SA, (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of molecular endocrinology 29: 23-39.
39. Defrance M, Touzet H, (2006) Predicting transcription factor binding sites using local over-representation and comparative genomics. BMC Bioinformatics 7: 396.
40. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378.
41. Kuhn H, Frank-Kamenetskii MD, Demidov VV, (2001) High-purity preparation of a large DNA dumbbell. Antisense Nucleic Acid Drug Dev 11: 149-153.
42. Ishibe S, Cantley LG, (2008) Epithelial-mesenchymal-epithelial cycling in kidney repair. Curr Opin Nephrol Hypertens 17: 379-385.
43. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, et al. (2008) Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 130: 481-494.
44. Vavouri T, Lehner B, (2009) Conserved noncoding elements and the evolution of animal body plans. Bioessays 31: 727-735.
45. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, et al. (2004) Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18: 1131-1143.
46. Robson EJ, Khaled WT, Abell K, Watson CJ, (2006) Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation 74: 254-264.
47. Weinberg RA, (2008) Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 10: 1021-1023.
48. Leung-Hagesteijn C, Hu MC, Mahendra AS, Hartwig S, Klamut HJ, et al. (2005) Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis. Mol Cell Biol 25: 3648-3657.
49. Kim SJ, Wagner S, Liu F, O'Reilly MA, Robbins PD, et al. (1992) Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358: 331-334.
50. Ross KR, Corey DA, Dunn JM, Kelley TJ, (2007) SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal 19: 923-931.
51. Zhang X, Yang J, Li Y, Liu Y, (2005) Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol 288: F16-26.
52. Subramanian SV, Polikandriotis JA, Kelm RJ Jr, David JJ, Orosz CG, et al. (2004) Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators. Mol Biol Cell 15: 4532-4543.
53. Johnsen SA, Subramaniam M, Janknecht R, Spelsberg TC, (2002) TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene 21: 5783-5790.
54. Subramaniam M, Hawse JR, Rajamannan NM, Ingle JN, Spelsberg TC, (2010) Functional role of KLF10 in multiple disease processes. Biofactors 36: 8-18.
55. Plisov SY, Ivanov SV, Yoshino K, Dove LF, Plisova TM, et al. (2000) Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display. Genesis 27: 22-31.
56. Tomita N, Kashihara N, Morishita R, (2007) Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease. Clin Exp Nephrol 11: 7-17.
57. Lok CN, Ehrlich HP, White SL, Buttolph TR, Cutroneo KR, et al. (2008) Oligodeoxynucleotide decoy therapy blocks type 1 procollagen transcription and the prolyl hydroxylase beta subunit translation. J Cell Biochem 103: 1066-1075.
58. Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, et al. (2003) Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 66: 1189-1198.
59. Cheng GZ, Zhang W, Wang LH, (2008) Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res 68: 957-960.
60. Valdes F, Alvarez AM, Locascio A, Vega S, Herrera B, et al. (2002) The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res 1: 68-78.
61. Peter IS, Davidson EH, (2011) Evolution of gene regulatory networks controlling body plan development. Cell 144: 970-985.
62. Siegel PM, Massague J, (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nature reviews Cancer 3: 807-821.
63. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 99: 12877-12882.
64. Moustakas A, Heldin CH, (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
65. Gotea V, Visel A, Westlund JM, Nobrega MA, Pennacchio LA, et al. (2010) Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res.
66. Uhl JD, Cook TA, Gebelein B, (2010) Comparing anterior and posterior Hox complex formation reveals guidelines for predicting cis-regulatory elements. Developmental biology 343: 154-166.
67. Kubo A, Suzuki N, Yuan X, Nakai K, Satoh N, et al. (2010) Genomic cis-regulatory networks in the early Ciona intestinalis embryo. Development 137: 1613-1623.
68. Morishita R, Higaki J, Tomita N, Ogihara T, (1998) Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 82: 1023-1028.
69. Cutroneo KR, (2007) TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 15 (Suppl 1): S54-60.
70. Fulton DL, Sundararajan S, Badis G, Hughes TR, Wasserman WW, et al. (2009) TFCat: the curated catalog of mouse and human transcription factors. Genome biology 10: R29.
71. Le Bechec A, Portales-Casamar E, Vetter G, Moes M, Zindy PJ, et al. (2011) MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model. BMC bioinformatics 12: 67.